For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Restylane-L Side of Face | Restylane with Lidocaine gel(Restylane-L) side of the face. Injection occurs on Day 1 only. Injection amount is determined by achieving the optimal cosmetic results (variable). | None | None | 0 | 60 | 46 | 60 | View |
| Restylane Side of Face | The Restylane gel side of the face. Injection occurs on Day 1 only. Injection amount is determined by achieving the optimal cosmetic results (variable). | None | None | 0 | 60 | 46 | 60 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Ecchymosis | None | Vascular disorders | None | View |
| Edema | None | General disorders | None | View |
| Erythema | None | General disorders | None | View |
| Tenderness | None | General disorders | None | View |
| Pain | None | General disorders | None | View |
| Pruitis | None | General disorders | None | View |
| Papule | None | General disorders | None | View |
| Vasospasm | None | General disorders | None | View |